Home » Speakers

Speakers

8th Expanded Access Progammes World Congress 2025 Europe

Comprehensive Analysis on Executing Expanded Access Programmes

Wednesday 19th - Thursday 20th March 2025

Dr David Gillen

Chief Medical Officer

Norgine

Katja Berg

Innovative Value and Access Strategy

AstraZeneca

ADAM JONES

Vice President International Medical

Amicus Therapeutics

Sara Radenovic*

Director, Managed Access

GSK

SHEELA UPADHYAYA

Chair Elect, Rare Disease Special Interest Group

ISPOR

DAN LEWI

Head of Business Development and Patient Advocacy

Pulse infoframe Inc., Co- founder, CATS Foundation

JENNIFER GRIGONIS

Sr. Director Business Development, EAP

Bionical Emas

Lindsay Randall

Founder, CEO, Mother

Arthur’s Quest

Dr. Alberto Calabrò

Patient Access Program and Supply Leader

F. Hoffmann-La Roche Ltd

Ana Tediosi

Head of Expanded Access Strategy

WEP Clinical

DR MICHELE AFIF

CEO

The Brain Tumour Charity

Pedro Franco

Sr Director, Head, Europe Global Regulatory & Scientific Policy

Merck Healthcare

JULIE POWELL

Marketing & Communications Director

Pleco Therapeutics

Carole Scrafton

Director & Co-Founder

Flutters and Strutters

JULIET HULSE

Head of Clinical Operations

Pulse infoframe Inc.

DANIEL O’CONNOR

Director, Regulatory Policy and Early Access

ABPI

Bob Stevens

Group CEO

MPS Society

DR POOJA TAKHAR

Joint Chief Executive Shortly

Tuberous Sclerosis Association

DR. RÜDIGER SCHULZE

Vice President and General Manager

DACH, Ultragenyx

Senior Representative

Awaiting for Photo & Bio

Coming Soon

Senior Representative

Awaiting for Photo & Bio

Coming Soon

Senior Representative

Awaiting for Photo & Bio

Coming Soon

Senior Representative

Awaiting for Photo & Bio

Coming Soon

Senior Representative

Awaiting for Photo & Bio

Coming Soon

Scroll to Top